09.00 – 10.30

Plenarveranstaltung:
Prozess und Outcome in der Psychotherapie /

Plenary session: Process and outcome in psychotherapy

·      P. Fonagy (London):
What works for whom?

11.00 – 12.30

13.00 - 13.45

Wissenschaftliche Symposien und State of the Art Vorträge / Scientific symposia and state of the art lectures

Sonderveranstaltung aus aktuellem Anlass der Revision des DSM-V / Lunchmeeting - Discussion Group

·      EACLPP Symposium: International guidelines for medically unexplained symptoms
Chair:  Th. Herzog (Göppingen) W. Söllner (Nürnberg)
1. The EACLPP Approach to developing guidelines for medically unexplained symptoms, F. Creed (Manchester, UK)
2. Beyond somatoform disorders: Classification of bodily distress, P. Fink (Aarhus, Denmark)
3. Recently developed guidelines for medically unexplained symptoms, P. Henningsen (Munich, Germany) 

Chairs: F. Creed (Manchester, UK), P. Henningsen (Munich, Germany)

"Somatic Symptom Disorders chapter of DSM-V: Update and Discussion" F. Creed (Manchster, UK)(English Track)

14.00–15.30

Wissenschaftliche Symposien und State of the Art Vorträge / Scientific symposia and state of the art lectures

·   Psychotherapy of Borderline Personality Disorders
Moderation: K. Lieb (Mainz), M. Bohus (Mannheim)
1. Efficacy and mechanism of action of dialectic behavioural therapy for borderline personality disorder M. Bohus (Mannheim)
2. Schematherapy for Borderline personality disorder, A.Arntz (Maastricht, Niederlande)
3. Metaanalysis of psychotherapeutic treatments in borderline personality disorder, K. Lieb (Mainz)

·   Cardivascular risks in the general population an intervention strategies - cardiological and psychosomatic perspectives
Chairs: T. Münzel (Mainz), M.E. Beutel (Mainz)
1. Do genomics and clinical markers help to idnetify cardiovascular risk in the community? The Gutenberg Heart Study, S. Blankenberg (Mainz)
2. Associations of psychosocial risk factors with cardiovascular diseases - first cross sectional results of the Gutenberg Heart Study, M. Michal (Mainz)
3. Who benefits from psychotherapy after myocardial infarction?, N. Schneiderman (Miami, USA) 

16.00 –17.30

Wissenschaftliche Symposien und State of the Art Vorträge / Scientific symposia and state of the art lectures

·      Development of a New Generation of Patient-Reported Outcome (PRO) Measures
Moderation: B. Loewe (Hamburg), M. Rose (Hamburg)
1. Introduction into Item Response Theory and Computer Adaptive Testing, J. Bjorner (Boston, USA)
2. Development of the KIDSCREEN - An European Initiative to Improve Health Assessment for Children, U. Ravens-Sieberer (Hamburg), M. Erhart 
3. The Patient-Reported Outcome Measurement Information System (PROMIS) - A NIH Keyroad Initiative to Utilize CATs for Health Outcome Measurement, M. Rose (Hamburg)

08.30 –10.00

Plenarveranstaltung:
Psychotherapie in der Psychosomatischen Medizin /

Plenary session:
Psychotherapy in psychosomatic medicine 

·    R. Lane (Tucson):

    Affect and psychotherapy 

10.30–12.00

Wissenschaftliche Symposien und State of the Art Vorträge / Scientific symposia and state of the art lectures

·   Evidence based psychosocial intervention that reduce somatic disease risk
Chairs: K. Orth-Gomér (Stockholm, Sweden), H.C. Deter (Berlin, Germany)
1. New biological risk factors of coronary artery disease - is there a modulation by behavioural interventions? N. Schneiderman (Miami, USA)
2. New support for the efficacy of stress reductioin in the Stockholm Women Intervention Trial on Coronary Heart Disease, SWITCHD, K. Orth-Gomér (Stockholm, Sweden)
3. New evidence of cognitive interventions from Hungarian men and women, P. Balog (Budapest, Hungary)
4. Integrating psychosomatic principles in European preventive guidelines and recommendations, C. Albus (Cologne, Germany)               

13.30 – 15.00

Wissenschaftliche Symposien und State of the Art Vorträge / Scientific symposia and state of the art lectures

·   Psychoneuroallergology - main branch of psychosomatics
Chairs: I.B. Iamandescu (Bucharest, Rumania), H.-C. Deter (Berlin)
1. Bronchial asthma with psychogenic triggers, I.B. Iamandescu (Bucharest, Rumania)
2. Psychological factors involved in therapeutic adherence at asthmatic patients, O. Popa-Velea (Bucharest, Rumania)
3. Quality of life in allergic patients, A.I. Mihailescu (Bucharest, Rumania)
4. Psychosomatic and somatic aspects of allergic rhinitis.  Some experimental contributions, I. Cioca (Bucharest, Rumania), I.B. Iamandescu

15.30 – 17.00

·   DISCOS - "Disorders and Coherence of the Embodied Self" Embodiment as crucial interface of the biological and psychosocial approaches to the human self and its disorders  
Chairs: H. Sattel (Heidelberg), P. Henningsen (München)
1. DISCOS - "Disorders and Coherence of the Embodied Self": An introduction into the project., T. Fuchs (Heidelberg)
2. Individual and interactional autonomy in therapeutic change, H. de Jaegher (Heidelberg)
3. The Medical Self: Therapy and Ethics, L. Lees (München)
4. DISCOS: any impact for psychosomatic medicine?, P. Henningsen (München)

11.30 –12.30

Plenarveranstaltung:
Psychotherapie in der Somatischen Medizin /

Plenary session:
Psychotherapy in somatic medicine

·    David Spiegel (Stanford):

     “Mind over Matter”  (Carus Lecture)

Kurs-

Nummer

Titel

Dozent

Zeit und Ort

Gebühr

G1

Mini course in behavioral medicine and psychoneuroimmunology

Y. Gidron

(Brüssel)

Do. 14:00-15:30 u. 16:00-17:30, Fr. 15:30-17:00 (Raum P201), Sa. 14:00-15:30 (Raum P15)

50 Euro / 8 UE

S5

Workshop: Praxis der supportiv-expressiven Therapie (SET) für Krebspatienten

D. Spiegel (Stanford),

W. Söllner

(Nürnberg)

Sa. 14:00-15:30 u. 16:00-17:30 (Raum P12)

30 Euro /4 UE